Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Gross Profit (2016 - 2025)

Historic Gross Profit for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $8.4 billion.

  • Bristol Myers Squibb's Gross Profit rose 1162.02% to $8.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $34.3 billion, marking a year-over-year decrease of 21.85%. This contributed to the annual value of $34.3 billion for FY2025, which is 21.55% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Gross Profit of $8.4 billion as of Q4 2025, which was up 1162.02% from $8.8 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Gross Profit ranged from a high of $9.6 billion in Q4 2021 and a low of $7.5 billion during Q4 2024
  • Its 5-year average for Gross Profit is $8.8 billion, with a median of $8.8 billion in 2022.
  • As far as peak fluctuations go, Bristol Myers Squibb's Gross Profit skyrocketed by 2450.87% in 2021, and later tumbled by 1376.55% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Gross Profit stood at $9.6 billion in 2021, then dropped by 8.47% to $8.8 billion in 2022, then fell by 0.92% to $8.7 billion in 2023, then dropped by 13.77% to $7.5 billion in 2024, then rose by 11.62% to $8.4 billion in 2025.
  • Its last three reported values are $8.4 billion in Q4 2025, $8.8 billion for Q3 2025, and $8.9 billion during Q2 2025.